{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:35:36Z","timestamp":1776605736626,"version":"3.51.2"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/mph.0b013e3182532078","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:27:59Z","timestamp":1371158879000},"page":"395-397","source":"Crossref","is-referenced-by-count":15,"title":["Cardiac Failure 30 Years After Treatment Containing Anthracycline for Childhood Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"34","author":[{"given":"John M.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca E.","family":"Scully","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Sallan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Lipshultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210227","first-page":"5601","article-title":"Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.","volume":"43","author":"Sallan","year":"1983","journal-title":"Cancer Res"},{"key":"R2-17-20210227","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","article-title":"Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.","volume":"23","author":"Lipshultz","year":"2005","journal-title":"J Clin Oncol"},{"key":"R3-17-20210227","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2007.14.9401","article-title":"Anthracycline cardiotoxicity: from bench to bedside.","volume":"26","author":"Gianni","year":"2008","journal-title":"J Clin Oncol"},{"key":"R4-17-20210227","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mpo.2950020205","article-title":"Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report.","volume":"2","author":"Furman","year":"1976","journal-title":"Med Pediatr Oncol"},{"key":"R5-17-20210227","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ncponc0818","article-title":"Heart failure in childhood cancer survivors.","volume":"4","author":"Lipshultz","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"R6-17-20210227","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N Engl J Med"},{"key":"R7-17-20210227","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","article-title":"Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.","volume":"332","author":"Lipshultz","year":"1995","journal-title":"N Engl J Med"},{"key":"R8-17-20210227","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa035153","article-title":"The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.","volume":"351","author":"Lipshultz","year":"2004","journal-title":"N Engl J Med"},{"key":"R9-17-20210227","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1200\/JCO.2005.01.9232","article-title":"Gender differences in p-glycoprotein: drug toxicity and response.","volume":"23","author":"Davis","year":"2005","journal-title":"J Clin Oncol"},{"key":"R10-17-20210227","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00280-008-0854-z","article-title":"Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.","volume":"64","author":"Thompson","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"R11-17-20210227","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.1997.15.4.1544","article-title":"Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.","volume":"15","author":"Krischer","year":"1997","journal-title":"J Clin Oncol"},{"key":"R12-17-20210227","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1200\/JCO.2008.16.3527","article-title":"Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.","volume":"26","author":"Garmey","year":"2008","journal-title":"J Clin Oncol"},{"key":"R14-17-20210227","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure.","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"key":"R16-17-20210227","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0002-9149(03)00031-6","article-title":"Body composition and prognosis in chronic systolic heart failure: the obesity paradox.","volume":"91","author":"Lavie","year":"2003","journal-title":"Am J Cardiol"},{"key":"R17-17-20210227","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1158\/1055-9965.EPI-10-0163","article-title":"Characteristics and determinants of adiposity in pediatric cancer survivors.","volume":"19","author":"Miller","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R18-17-20210227","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.107.721027","article-title":"Effects of bariatric surgery on cardiovascular function.","volume":"118","author":"Ashrafian","year":"2008","journal-title":"Circulation"},{"key":"R19-17-20210227","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4065\/mcp.2010.0103","article-title":"Association between direct measures of body composition and prognostic factors in chronic heart failure.","volume":"85","author":"Oreopoulos","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"R21-17-20210227","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2008-0784","article-title":"Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.","volume":"93","author":"Pilz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-17-20210227","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1200\/JCO.2002.12.102","article-title":"Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.","volume":"20","author":"Lipshultz","year":"2002","journal-title":"J Clin Oncol"},{"key":"R23-17-20210227","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.","volume":"342","author":"Felker","year":"2000","journal-title":"N Engl J Med"},{"key":"R24-17-20210227","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","article-title":"Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines.","volume":"22","author":"Silber","year":"2004","journal-title":"J Clin Oncol"},{"key":"R25-17-20210227","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/adc.66.8.985","article-title":"Long term survival after heart transplantation for doxorubicin induced cardiomyopathy.","volume":"66","author":"Arico","year":"1991","journal-title":"Arch Dis Child"},{"key":"R26-17-20210227","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0959-8049(96)00028-7","article-title":"Cardiac transplantation in childhood cancer survivors in Great Britain.","volume":"32A","author":"Levitt","year":"1996","journal-title":"Eur J Cancer"},{"key":"R28-17-20210227","first-page":"375","article-title":"Pediatric heart transplantation for doxorubicin-induced cardiomyopathy.","volume":"11","author":"McManus","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"R29-17-20210227","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.healun.2003.08.014","article-title":"Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare.","volume":"23","author":"Ward","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R30-17-20210227","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1034\/j.1399-3046.1999.00045.x","article-title":"Heart transplantation in children: indications. Report of the Ad Hoc Subcommittee of the Pediatric Committee of the American Society of Transplantation (AST).","volume":"3","author":"Fricker","year":"1999","journal-title":"Pediatr Transplant"},{"key":"R31-17-20210227","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer.","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"R32-17-20210227","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ppedcard.2007.11.011","article-title":"Pediatric cardiomyopathy as a chronic disease: a perspective on comprehensive care programs.","volume":"25","author":"Bublik","year":"2008","journal-title":"Prog Pediatr Cardiol"},{"key":"R33-17-20210227","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.2008.21.1433","article-title":"Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.","volume":"27","author":"Zeltzer","year":"2009","journal-title":"J Clin Oncol"},{"issue":"pt 1","key":"R34-17-20210227","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1542\/peds.110.1.42","article-title":"Psychological outcomes in long-term survivors of childhood leukemia, Hodgkins disease, and non-Hodgkins lymphoma: a report from the Childhood Cancer Survivor Study.","volume":"110","author":"Zebrack","year":"2002","journal-title":"Pediatrics"},{"key":"R35-17-20210227","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1200\/JCO.2009.22.8635","article-title":"Suicide ideation in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.","volume":"28","author":"Recklitis","year":"2010","journal-title":"J Clin Oncol"},{"key":"R36-17-20210227","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2006.06.5409","article-title":"Suicidal ideation and attempts in adult survivors of childhood cancer.","volume":"24","author":"Recklitis","year":"2006","journal-title":"J Clin Oncol"},{"key":"R37-17-20210227","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.amjmed.2010.06.016","article-title":"Risk of suicide after long-term follow-up from bariatric surgery.","volume":"123","author":"Tindle","year":"2010","journal-title":"Am J Med"},{"key":"R38-17-20210227","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008.","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"R41-17-20210227","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjc.6601904","article-title":"Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.","volume":"91","author":"Pein","year":"2004","journal-title":"Br J Cancer"},{"key":"R42-17-20210227","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s002800000177","article-title":"Phase I study of liposomal annamycin.","volume":"46","author":"Booser","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"R43-17-20210227","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/14656566.8.8.1039","article-title":"Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management.","volume":"8","author":"Barry","year":"2007","journal-title":"Expert Opin Pharmacother"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e3182532078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:12:30Z","timestamp":1620965550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201207000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3182532078","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}